Editas Medicine, Inc. (EDIT)
3.00
-0.11
(-3.54%)
USD |
NASDAQ |
Aug 24, 16:00
3.00
0.00 (0.00%)
After-Hours: 20:00
Editas Medicine Total Liabilities (Quarterly) : 132.08M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 132.08M |
| March 31, 2026 | 144.93M |
| December 31, 2025 | 159.25M |
| September 30, 2025 | 188.30M |
| June 30, 2025 | 191.39M |
| March 31, 2025 | 201.23M |
| December 31, 2024 | 207.32M |
| September 30, 2024 | 151.93M |
| June 30, 2024 | 152.79M |
| March 31, 2024 | 145.95M |
| December 31, 2023 | 150.06M |
| September 30, 2023 | 144.19M |
| June 30, 2023 | 142.04M |
| March 31, 2023 | 146.63M |
| December 31, 2022 | 153.64M |
| September 30, 2022 | 116.28M |
| June 30, 2022 | 115.42M |
| March 31, 2022 | 110.35M |
| December 31, 2021 | 123.84M |
| September 30, 2021 | 130.22M |
| June 30, 2021 | 142.52M |
| March 31, 2021 | 142.30M |
| Date | Value |
|---|---|
| December 31, 2020 | 179.02M |
| September 30, 2020 | 156.00M |
| June 30, 2020 | 228.71M |
| March 31, 2020 | 232.17M |
| December 31, 2019 | 246.45M |
| September 30, 2019 | 162.37M |
| June 30, 2019 | 162.56M |
| March 31, 2019 | 161.75M |
| December 31, 2018 | 184.22M |
| September 30, 2018 | 163.18M |
| June 30, 2018 | 162.20M |
| March 31, 2018 | 156.47M |
| December 31, 2017 | 165.18M |
| September 30, 2017 | 161.34M |
| June 30, 2017 | 183.84M |
| March 31, 2017 | 188.58M |
| December 31, 2016 | 94.58M |
| September 30, 2016 | 71.98M |
| June 30, 2016 | 62.27M |
| March 31, 2016 | 47.44M |
| December 31, 2015 | 32.56M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Geron Corp. | 300.40M |
| Novavax, Inc. | 1.146B |
| Recursion Pharmaceuticals, Inc. | 297.66M |
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 237.36M |
| Shareholders Equity (Quarterly) | 105.28M |
| Debt to Equity Ratio | 0.6768 |
| Current Ratio | 3.186 |
| Net Debt Paydown Yield | -1.61% |